Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway
- 16 March 2024
- journal article
- research article
- Published by Elsevier in Translational Research
- Vol. 268, 63-78
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
- Regional Centre for Biotechnology
- Life Sciences Institute
This publication has 67 references indexed in Scilit:
- Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROSJournal of Clinical Laboratory Analysis, 2022
- Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective studyClinical Oral Investigations, 2021
- Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcomeCancer Communications, 2021
- Zebrafish Embryos Allow Prediction of Nanoparticle Circulation Times in Mice and Facilitate Quantification of Nanoparticle–Cell InteractionsSmall, 2020
- YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTENFEBS Open Bio, 2019
- Uptake and Intracellular Fate of Engineered Nanoparticles in Mammalian Cells: Capabilities and Limitations of Transmission Electron Microscopy—Polymer‐Based NanoparticlesAdvanced Materials, 2018
- Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer2018
- Smart Multifunctional Hollow Microspheres for the Quick Release of Drugs in Intracellular Lysosomal CompartmentsAngewandte Chemie International Edition, 2011
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdvanced Drug Delivery Reviews, 2011
- Predicting the Prognosis of Oral Squamous Cell Carcinoma After First RecurrenceJAMA Otolaryngology–Head & Neck Surgery, 2010